DRPLA_ATN1

Gene
ATN1
Disease
DRPLA
Inheritance
AD
Classification
Definitive
Total Score
12.5
Publications Reviewed
5
Publication Span
43.61 years
Last Updated
05/22/2026
Curator(s)
Macayla Weiner, Laurel Hiatt, Harriet Dashnow

Description

Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder associated with expansion of the ATN1 CAG repeat, which encodes an expanded polyglutamine tract. The uploaded evidence includes a clinical-neuropathologic series of five families with myoclonus, epilepsy, dementia, ataxia and choreoathetosis with dentatorubral-pallidoluysian degeneration, and a molecular study showing ATN1 gene structure, ubiquitous 4.5 kb transcript expression, and predicted protein motifs. A TR-specific humanized ATN1 expansion mouse model recapitulates relevant phenotypes, and ASO treatment rescues several disease phenotypes in this model.

Genetic evidence

Total: 8

Singular EvidenceProbandsPMID:68084176Five families with hereditary dentatorubral-pallidoluysian atrophy were described; 16 patients were clinically summarized, with autosomal dominant inheritance inferred from multigenerational parent-to-child transmission.
Collective EvidenceAllelePMID:8136826 PMID:77788502An inverse correlation has been observed between the age at onset and the size of the expanded ATN1 CAG repeat in individuals with DRPLA.
2 rows

Experimental evidence

Total: 4.5

FunctionRegulatory impactPMID:78420160.5Northern blot analysis detected a single 4.5 kb ATN1 transcript in all examined human tissues; after beta-actin normalization, expression varied within ~5-fold and was relatively high in brain, ovary, testis, and prostate.
ModelsNon-human model organismPMID:416243322Humanized ATN1 expansion mouse model in which one allele of mouse Atn1 is completely replaced by human ATN1 with a pure 112 CAG repeat expansion. The model recapitulates relevant phenotype including behavioral alterations, reduced brain size, and aggregate accumulation.
RescueRescue in non-human model organismPMID:416243322Treatment of a humanized ATN1 expansion mouse model with human ATN1-targeting ASOs rescue several disease phenotypes including behavioral phenotypes and transcriptional dysregulation in the cerebellum.
3 rows

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.